{
  "id": "adv_mhgap#referral_6d982472",
  "content": "and tardive dyskinesia. Treat with anticholinergic medications\nlithium prescription. or carbamazepine may be used. Offer maintenance\nwhen indicated and available (see Table 2).\ntreatment in primary care settings under specialist\nHaloperidol and risperidone: consider haloperidol and\n– Metabolic changes: weight gain, high blood pressure, supervision.\nincreased blood sugar and cholesterol. risperidone only if no clinical or laboratory monitoring is\navailable to start lithium or valproate. Risperidone can be\n– ECG changes (prolonged QT interval): monitor ECG\nused as an alternative to haloperidol in individuals with\nif possible.\nbipolar mania if availability can be assured, and cost is not a\n– Neuroleptic malignant syndrome (NMS): a rare,\nconstraint.\npotentially life-threatening disorder characterized by muscular\nrigidity, elevated temperature, and high blood pressure.\nPSYCHOSES 41\n42\nPSY 2\nPSYCHOSES Management\nTABLE 1: Antipsychotic medications\nMEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nHALOPERIDOL Start 1.5-3 mg daily. Common: sedation, dizziness, blurred vision, Caution in patients with: kidney disease, liver disease,\nIncrease as needed (maximum 20 mg daily). dry mouth, urinary retention, constipation. cardiac disease, long QT syndrome or taking QT-prolonging medications.\nRoute: oral (p.o.) or intramuscular (i.m.). Monitor ECG if possible.\nSerious: orthostatic hypotension, extrapyramidal side\neffects (EPS), ECG changes (prolonged QT interval),",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Referral and tardive dyskinesia. Treat with anticholinergic medications\nlithium prescription. or carbamazepine may be used. Offer maintenance\nwhen indicated and available (see Table 2).\ntreatment in primary care settings under specialist\nHaloperidol and risperidone: consider haloperidol and\n– Metabolic changes: weight gain, high blood pressure, supervision.\nincreased blood sugar and cholesterol. risperidone only if no clinical or laboratory monitoring is\navailable to start lithium or valproate. Risperidone can be\n– ECG changes (prolonged QT interval): monitor ECG\nused as an alternative to haloperidol in individuals with\nif possible.\nbipolar mania if availability can be assured, and cost is not a\n– Neuroleptic malignant syndrome (NMS): a rare,\nconstraint.\npotentially life-threatening disorder characterized by muscular\nrigidity, elevated temperature, and high blood pressure.\nPSYCHOSES 41\n42\nPSY 2\nPSYCHOSES Management\nTABLE 1: Antipsychotic medications\nMEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nHALOPERIDOL Start 1.5-3 mg daily. Common: sedation, dizziness, blurred vision, Caution in patients with: kidney disease, liver disease,\nIncrease as needed (maximum 20 mg daily). dry mouth, urinary retention, constipation. cardiac disease, long QT syndrome or taking QT-prolonging medications.\nRoute: oral (p.o.) or intramuscular (i.m.). Monitor ECG if possible.\nSerious: orthostatic hypotension, extrapyramidal side\neffects (EPS), ECG changes (prolonged QT interval), And tardive dyskinesia. treat with anticholinergic medications\nlithium prescription."
}